BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36228269)

  • 1. Real-world Evidence of COVID-19 Vaccines Effectiveness in Solid-organ Transplant Recipient Population in Colombia: A Study Nested in the Esperanza Cohort.
    Pinto-Álvarez M; Fernández-Niño JA; Arregocés-Castillo L; Rojas-Botero ML; Palacios AF; Galvis-Pedraza M; Ruiz-Gomez F
    Transplantation; 2023 Jan; 107(1):216-224. PubMed ID: 36228269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort.
    Arregocés-Castillo L; Fernández-Niño J; Rojas-Botero M; Palacios-Clavijo A; Galvis-Pedraza M; Rincón-Medrano L; Pinto-Álvarez M; Ruiz-Gómez F; Trejo-Valdivia B
    Lancet Healthy Longev; 2022 Apr; 3(4):e242-e252. PubMed ID: 35340743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
    Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
    Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a Fourth COVID-19 mRNA Vaccine Dose Against the Omicron Variant in Solid Organ Transplant Recipients.
    Naylor KL; Knoll GA; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Kim SJ
    Transplantation; 2024 Jan; 108(1):294-302. PubMed ID: 38098159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients.
    Huh K; Kang M; Kim YE; Choi Y; An SJ; Seong J; Go MJ; Kang JM; Jung J
    J Infect Dis; 2024 Apr; 229(4):1026-1034. PubMed ID: 38097377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
    Subramanian V
    J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
    Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
    Aslam S; Adler E; Mekeel K; Little SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.
    Naylor KL; Kim SJ; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Knoll GA
    Am J Transplant; 2022 Sep; 22(9):2228-2236. PubMed ID: 35578576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
    Sakuraba A; Luna A; Micic D
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020-2021: A Nationwide Multi-Register Comparative Cohort Study.
    Søfteland JM; Li H; Magnusson JM; Leach S; Friman V; Gisslén M; Felldin M; Schult A; Karason K; Baid-Agrawal S; Wallquist C; Nyberg F
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world effectiveness of COVID-19 vaccines among Colombian adults: A retrospective, population-based study of the ESPERANZA cohort.
    Rojas-Botero ML; Fernández-Niño JA; Arregocés-Castillo L; Palacios-Clavijo A; Pinto-Álvarez M; Ruiz-Gómez F
    PLOS Glob Public Health; 2023; 3(9):e0001845. PubMed ID: 37682804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pragmatic outreach pilot to understand and overcome barriers to COVID-19 vaccination in abdominal organ transplant.
    Serper M; Liu CH; Blumberg EA; Burdzy AE; Veasey S; Halpern S; Lander E; Sigafus MR; Bloom RD; Dunn TB; Abt PL; Reddy KR; Mehta SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13722. PubMed ID: 34496115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021.
    Starrfelt J; Danielsen AS; Buanes EA; Juvet LK; Lyngstad TM; Rø GØI; Veneti L; Watle SV; Meijerink H
    BMC Med; 2022 Sep; 20(1):278. PubMed ID: 36050718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study.
    Overvad M; Koch A; Jespersen B; Gustafsson F; Krause TG; Hansen CH; Ethelberg S; Obel N
    Am J Transplant; 2022 Nov; 22(11):2627-2636. PubMed ID: 35801493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.